General Information of the Compound
Compound ID
CP0253094
Compound Name
4-[(6-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol
    Show/Hide
Structure
Formula
C16H12N4OS
Molecular Weight
308.366
Canonical SMILES
Oc1ccc(Cc2nnc3ccc(nn23)-c2ccsc2)cc1
    Show/Hide
InChI
InChI=1S/C16H12N4OS/c21-13-3-1-11(2-4-13)9-16-18-17-15-6-5-14(19-20(15)16)12-7-8-22-10-12/h1-8,10,21H,9H2
    Show/Hide
InChIKey
LRCUPNMGFPJMTL-UHFFFAOYSA-N
Physicochemical Property
logP
3.1492
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
63.31
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44576915
ChEMBL ID
CHEMBL497117
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001061 PC-2 [Human pancreatic carcinoma China] Homo sapiens (Human)  1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 4 nM